In Vitro Diagnostics (IVD) are a subset of medical devices that are essential to improve health outcomes, and are critical tools in emergencies like we're facing today.
In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.
Most treatment decisions today are based on IVD results. They ensure that the right patients receive the right treatments, thus protecting patients from incorrect, ineffective or, at worst, harmful treatments; and reducing unnecessary healthcare expenditures.
Rapid IgM-IgG Combined Antibody Test for COVID-19 is a lateral flow immunoassay used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.
Antibody tests are crucial in this battle by detecting infections, especially in people with few or no symptoms - CDC
The COVID-19 IgG/IgM Rapid Test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 novel coronavirus in human whole blood, serum or plasma.
The COVID-19 IgG/IgM Rapid Test is intended for professionals within highly complex settings and or pharmacies.
The test strip contains a colloidal gold-labeled recombinant novel coronavirus antigen and quality control antibody colloidal gold marker, two detection lines (G and M lines) and one quality control line (C) fixed on a nitrocellulose membrane.
M is fixed with monoclonal anti-human IgM antibody for detecting the novel coronavirus IgM antibody. G is fixed with a monoclonal anti human IgG antibody for detecting the novel coronavirus IgG antibody. The quality control antibody is fixed on the C line.
Pre-EUA Cleared
The Emergency Use Authorization (EUA) Program is an expedited clearance process in order to release medical devices while they are being reviewed by the FDA.
Our tests are manufactured by MedicalSystem Biotechnology Co., Ltd (SHE: 300439), a China-based publicly traded company that engages in the research, development and manufacturing of bio-tech pharmaceutical products. Its activity includes the provision of medical diagnostics and consultation services. Its products include in-vitro biochemical diagnostic reagents and instruments. The company was founded on July 22, 2003 and is headquartered in Ningbo, China.
Yes, the kit is CE-IVD Marked. The kit is widely used in China and Europe. It is manufactured by MedicalSystem Biotechnology Co., Ltd (SHE: 300439), a China-based publicly traded company engaged in the research and development, manufacturing and distribution of in-vitro diagnostic products.
Millions of our rapid tests have been successfully distributed here in the US as well as in Italy, Germany, Malaysia, Ecuador, Indonesia, Chile, Saudi Arabia, Sweden, Poland, Finland, Brazil, Romania, and Australia among others.
It could take up to 8 - 11 days after exposure to the virus to have detectable IgM antibodies for SARS-CoV-2.
At this point, there is still much that is unknown about the serological aspects of this 2019 novel coronavirus (SARS-CoV-2). However, there is serological data from the 2002 SARS outbreak (SARS CoV) that shows detectable IgG antibodies 60 days after initial symptom onset. (Chen X et al. J Infect Dis. 2004;189(7):1158-63)
The COVID-19 IgG/IgM Rapid Test Cassette is NOT for the screening of donated blood.
The test protocol in the Package Insert is the best and only available instructions for the COVID-19 IgG/IgM Rapid Test Cassette.
U0002
There is an internal control line in the test cassette to assure proper protocol operation.
RapidIVD cannot interpret test results. If you are unsure of the test result, it is recommended that the test procedure is repeated. Please be sure to follow the test protocol carefully, and also be sure not to overfill the specimen well (S).
A negative COVID-19 IgG/IgM Rapid Test result does not rule out SARS-CoV-2 virus infection, particularly in those who have been in contact with the virus. Follow-up testing via CDC and/or FDA approved molecular diagnostic specifically for SARS-CoV-2 should be considered to rule out infection of SARS-CoV-2.
The run time on the test is 15 minutes after the specimen is applied to the cassette. The results cannot be read out after 20 minutes.
1-year from the date of manufacture.
The patient's insurance company should be contacted to determine coverage and pricing.
PMT Medical is an innovator and manufacturer of advanced medical equipment, and therapeutic devices. For the past 20 years, PMT Medical has established itself as a national contract holder with the VA and a nationally recognized distributor of advanced medical equipment.
See our pricing page or call for volume discounts.
Small size orders will ship within 1-2 business days. Larger orders can be scheduled with a 2-week lead time for delivery.
Yes